Detailed answers about KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED founded?
KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED was officially incorporated on 20 December 2022 and is registered under company number 14550446. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED?
KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED do?
KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED operates in the following sector: 86210 - General medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED's registered address?
The registered office address of KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED is 30 GOLDSMITH DRIVE, SANDBACH, CHESHIRE, UNITED KINGDOM, CW11 3GR. This is the official address filed with Companies House for legal and statutory correspondence.
Is KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED financially stable?
The most recent accounts for KAREN ATKINSON MEDICAL COMMUNICATIONS LIMITED were made up to 31 December 2024, filed as MICRO ENTITY. Next accounts are due by 30 September 2026.